Prostatype Genomics CFO Michael af Winklerfelt is leaving the company – recruitment process for the position has begun

Prostatype Genomics CFO Michael af Winklerfelt is leaving the company after three years. Michael will resign from his position as of December 4. The company has started the process of finding a replacement for the function as CFO.

"We are very grateful for all the work that Michael has carried out during his three years at Prostatype Genomics, in the management team and in close cooperation with the board. In everything from the group's financial management and financial strategy, to efforts in the transformation from a research and development activity to a commercially focused company and the internationalization of Prostatype Genomics. I want to thank Michael for his commitment, good efforts and a nice camaraderie during his time in Prostatype Genomics, and wish him all the best in the future", says Fredrik Persson, CEO of Prostatype Genomics.